Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Has results × lifileucel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 905 Carboplatin 781 Paclitaxel 739 pembrolizumab 719 Cisplatin 703 Bevacizumab 703 Gemcitabine 613 Docetaxel 573 Rituximab 547 Radiotherapy 534 Dexamethasone 506 Nivolumab 475 Doxorubicin 443 Fluorouracil 390 Capecitabine 376 Etoposide 358 Oxaliplatin 332 Cytarabine 331 Pemetrexed 330 Lenalidomide 326 Prednisone 324 fludarabine phosphate 314 Erlotinib Hydrochloride 313 Trastuzumab 298 Leucovorin 296 fludarabine 294 Vincristine 287 Filgrastim 283 Bortezomib 283 Cetuximab 272

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02360579 2026-03-25

LN-144

Iovance Biotherapeutics, Inc.

Phase 2 Completed

220 enrolled 16 charts

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡